Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
N/A
Synonyms :
relebactam
Class :
Beta-lactamase inhibitor
Dosage Forms & StrengthsÂ
Solution Â
N/AÂ Â
Administer as per physicians advised
Not determined Â
Refer to adult dosingÂ
meningococcal A C Y and W-135 diphtheria conjugate vaccine
may enhance the serum concentration of Betalactamase Inhibitors
may enhance the serum concentration of Betalactamase Inhibitors
may enhance the serum concentration of Betalactamase Inhibitors
may enhance the serum concentration of Betalactamase Inhibitors
may enhance the serum concentration of Betalactamase Inhibitors
trilaciclib decreases the efficacy of relebactam
When relebactam is used together with ouabain, this leads to reduction in relebactam excretion
the excretion of relebactam can be diminished when combined with aminohippuric acid
relebactam: it may decrease the excretion of CYP3A inhibitors
relebactam: it may decrease the excretion of CYP3A inhibitors
relebactam: it may decrease the excretion of CYP3A inhibitors
relebactam: it may decrease the excretion of CYP3A inhibitors
relebactam: it may decrease the excretion of CYP3A inhibitors
acemetacin may increase the serum concentration of penicillins
It may enhance the risk of adverse effects when combined with polypeptide antibiotic
probenecid has the potential to elevate the concentration serum of Beta-lactamase Inhibitors
Actions and SpectrumÂ
relebactam is a beta-lactamase inhibitor, and its main action is to block the activity of beta-lactamase enzymes produced by some bacteria. Beta-lactamases are enzymes that can break down and inactivate antibiotics like penicillin’s and cephalosporins.
Frequency not defined Â
None
Black Box WarningÂ
NoneÂ
Contraindication/Caution:Â
Contraindication:Â
Caution:Â
Pregnancy consideration:Â
Pregnancy category: N/AÂ
Lactation: Excretion into human milk is unknown Â
Pregnancy Categories:        Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women. Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.Â
Category N: There is no data available for the drug under this category.Â
Pharmacology Â
relebactam is a beta-lactamase inhibitor. Beta-lactamases are enzymes produced by bacteria that can hydrolyze and inactivate beta-lactam antibiotics like penicillin and cephalosporins. Â
relebactam works by binding to and inhibiting these enzymes, preventing them from breaking down beta-lactam antibiotics.Â
PharmacodynamicsÂ
relebactam allows these antibiotics to maintain their effectiveness against bacteria that would resistant due to beta-lactamase production.Â
PharmacokineticsÂ
Limited information available on ADME.Â
AdministrationÂ
relebactam is administered intravenously (IV) in the form of injection.
Patient information leafletÂ
Generic Name: relebactamÂ
Why do we use relebactam?Â
relebactam in combination with certain antibiotics to treat various bacterial infections like Complicated Intra-Abdominal Infections. relebactam in combination with specific antibiotics is used to treat Complicated urinary tract infections (cUTIs). Â